Cargando…

European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease

AIMS: The aim of this survey is to analyze how current recommendations on valvular heart disease (VHD) management have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sannino, Anna, Campbell, Sarah, Grapsa, Julia, Modine, Thomas, Barbanti, Marco, Chambers, John B, Zamorano, Jose L, Pibarot, Philippe, Garbi, Madalina, Vannan, Mani, Habib, Gilbert, Lancellotti, Patrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562836/
https://www.ncbi.nlm.nih.gov/pubmed/36262770
http://dx.doi.org/10.1093/ehjopen/oeac054
_version_ 1784808264500772864
author Sannino, Anna
Campbell, Sarah
Grapsa, Julia
Modine, Thomas
Barbanti, Marco
Chambers, John B
Zamorano, Jose L
Pibarot, Philippe
Garbi, Madalina
Vannan, Mani
Habib, Gilbert
Lancellotti, Patrizio
author_facet Sannino, Anna
Campbell, Sarah
Grapsa, Julia
Modine, Thomas
Barbanti, Marco
Chambers, John B
Zamorano, Jose L
Pibarot, Philippe
Garbi, Madalina
Vannan, Mani
Habib, Gilbert
Lancellotti, Patrizio
author_sort Sannino, Anna
collection PubMed
description AIMS: The aim of this survey is to analyze how current recommendations on valvular heart disease (VHD) management have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. METHODS AND RESULTS: A total of 33 questions, distributed via email to all European Society of Cardiology (ESC) affiliated countries through the newsletter of the ESC council on VHD, were answered by 689 respondents, mainly from tertiary care settings. The results of this survey showed that VHD patients are mostly managed by tertiary care centres, where multi-disciplinary heart teams are frequently a reality. Cardiac computed tomography (CT) is often used in the preprocedural planning of transcatheter interventions, particularly for sizing and deliverability assessment. Echocardiography represents the most widely used imaging modality in the diagnostic, intra-operative and follow-up phase of VHD patients. Cardiac magnetic resonance (CMR) is still largely underused, also for conditions such as mitral annular disjunction, or for the assessment of left ventricle volumes where it is considered as the gold standard, despite 3D volumes by echocardiography having proved good comparability with CMR. As for endocarditis, despite still underused, transesophageal echocardiography (TEE) represents the approach of choice for the diagnosis of native and prosthesis valve endocarditis (up to 46% of the respondents use it). In this context, positron emission tomography-CT is largely underused. CONCLUSION: There is widespread adoption of current recommendation on the evaluation of VHD and these are frequently used to guide patient management. Nonetheless, there are still many discrepancies across centres and countries which need to be addressed with the aim of improving patients’ management and outcomes and ultimately positively impacting on healthcare resources.
format Online
Article
Text
id pubmed-9562836
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95628362022-10-18 European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease Sannino, Anna Campbell, Sarah Grapsa, Julia Modine, Thomas Barbanti, Marco Chambers, John B Zamorano, Jose L Pibarot, Philippe Garbi, Madalina Vannan, Mani Habib, Gilbert Lancellotti, Patrizio Eur Heart J Open Original Article AIMS: The aim of this survey is to analyze how current recommendations on valvular heart disease (VHD) management have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. METHODS AND RESULTS: A total of 33 questions, distributed via email to all European Society of Cardiology (ESC) affiliated countries through the newsletter of the ESC council on VHD, were answered by 689 respondents, mainly from tertiary care settings. The results of this survey showed that VHD patients are mostly managed by tertiary care centres, where multi-disciplinary heart teams are frequently a reality. Cardiac computed tomography (CT) is often used in the preprocedural planning of transcatheter interventions, particularly for sizing and deliverability assessment. Echocardiography represents the most widely used imaging modality in the diagnostic, intra-operative and follow-up phase of VHD patients. Cardiac magnetic resonance (CMR) is still largely underused, also for conditions such as mitral annular disjunction, or for the assessment of left ventricle volumes where it is considered as the gold standard, despite 3D volumes by echocardiography having proved good comparability with CMR. As for endocarditis, despite still underused, transesophageal echocardiography (TEE) represents the approach of choice for the diagnosis of native and prosthesis valve endocarditis (up to 46% of the respondents use it). In this context, positron emission tomography-CT is largely underused. CONCLUSION: There is widespread adoption of current recommendation on the evaluation of VHD and these are frequently used to guide patient management. Nonetheless, there are still many discrepancies across centres and countries which need to be addressed with the aim of improving patients’ management and outcomes and ultimately positively impacting on healthcare resources. Oxford University Press 2022-09-02 /pmc/articles/PMC9562836/ /pubmed/36262770 http://dx.doi.org/10.1093/ehjopen/oeac054 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Sannino, Anna
Campbell, Sarah
Grapsa, Julia
Modine, Thomas
Barbanti, Marco
Chambers, John B
Zamorano, Jose L
Pibarot, Philippe
Garbi, Madalina
Vannan, Mani
Habib, Gilbert
Lancellotti, Patrizio
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease
title European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease
title_full European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease
title_fullStr European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease
title_full_unstemmed European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease
title_short European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease
title_sort european survey on valvular heart disease clinical experience from the european society of cardiology council on valvular heart disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562836/
https://www.ncbi.nlm.nih.gov/pubmed/36262770
http://dx.doi.org/10.1093/ehjopen/oeac054
work_keys_str_mv AT sanninoanna europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT campbellsarah europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT grapsajulia europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT modinethomas europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT barbantimarco europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT chambersjohnb europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT zamoranojosel europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT pibarotphilippe europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT garbimadalina europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT vannanmani europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT habibgilbert europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease
AT lancellottipatrizio europeansurveyonvalvularheartdiseaseclinicalexperiencefromtheeuropeansocietyofcardiologycouncilonvalvularheartdisease